New study: Glatiramer acetate in relapsing-remitting multiple sclerosis

Machine translation Machine translation
Authors [No authors listed]
Category Primary study
JournalDeutsche Apotheker Zeitung
Year 1998
Links
Treatment with glatiramer acetate slows progression in patients with relapsing-remitting multiple sclerosis and reduces the relapse rate. Over the course of treatment, an increasing effect of the therapy on the measured parameters becomes clearly evident. This is demonstrated by a study from the USA that has now been published.
This translation has been produced by an automated software. If you wish to submit your own translation, please send it to translations@epistemonikos.org
Epistemonikos ID: e6f8b172a8bf65fbec213cf85402e507ccf8889a
First added on: Feb 03, 2025
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: Deutsch

If you prefer to see the machine translation we assume you accept our terms of use